6Murtaugh MA, Jacobs DR. Correlates of urinary albumin exertion in young adult blacks. Epidemid ,2003,158 : 676.
7Hellemons ME, Kerschbaum J, Bakker S J, et al. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 di- abetes : a systematic review. Diabet Med ,2012,29 : 567-577.
8Kanauchi M, Akai Y, Hashimoto T. Transferrinuria in type 2 diabetic pa- tients with early nephropathy and tubulointerstitial injury. European Jour- nal of Internal Medicine,2002,13 : 190-193.
9Narita T, Hosoba M, Miura T, et al. Low dose of losartan decreased urina- ry excretions of lgG, transferrin, and ceruloplasmin without reducing albu-minutia in normoalbuminuric type 2 diabetic patients. Hormone and Met- abolic Research ,2008,40:292-295.
10Narita T,Flosoba M,Kakei M,et al. Increased urinary excretions of im- munoglobulin G, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care,2006, 29 : 142-144.
1Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens, 2013, 31(10): 1925-1938.
2Liu K, He S, Hong B, et al. Over time, do anthropometric measures still predict diabetes incidence in chinese han nationality population from chengdu community? Int J Endocrinol, 2013, 2013: 239376.
3Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003, 289(19): 2560-2572.
4Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens, 2010, 24(12): 779-785.
5Hellemons ME, Kerschbaum J, Bakker SJ, et al. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Diabet Med, 2012, 29(5): 567-577.
6Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med, 1997, 336(16): 1117-1124.
7Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA, 2003, 289(16): 2083-2093.
8Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension, 2006, 47(2): 296-308.
9Primatesta P, Falaschetti E, Gupta S, et al. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension, 2001, 37(2): 187-193.
10Fuchs FD, Chambless LE, Whelton PK, et al. Alcohol consumption and the incidence of hypertension: The Atherosclerosis Risk in Communities Study. Hypertension, 2001, 37(5): 1242-1250.
